Evidence map›Paper›PMID 42774747›Full record

ArticlePublic health in practice (Oxford, England)2026

Mapping medication adherence interventions across Europe: Expert perspectives from 35 countries.

S Mucherino, E Aarnio, M Qvarnström, G Hafez, M Kamusheva, I Potočnjak, I Trečiokiene, J Mihajlović, M Ekenberg, J F M van Boven and 2 more

Abstract read
In one paragraph

Article in Public health in practice (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

S MucherinoDepartment of Pharmacy, University of Naples Federico II, Naples, NA, Italy.
E AarnioSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
M QvarnströmDepartment of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.
G HafezDepartment of Pharmacology, Faculty of Pharmacy, Altinbas University, Istanbul, Turkey.
M KamushevaFaculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
I PotočnjakSestre Milosrdnice University Hospital Center; School of Medicine Catholic University of Croatia, Zagreb, Croatia.
I TrečiokieneFaculty of Medicine, Vilnius University, Vilnius, Lithuania.
J MihajlovićUniversity of Groningen, Department of Health Sciences, University Medical Center Groningen, Groningen, Netherlands.
M EkenbergDepartment of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.
J F M van BovenDepartment of Clinical Pharmacy and Pharmacology, Medication Adherence Expertise Center of the Northern Netherlands (MAECON), University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
F Leiva-FernandezMálaga-Valle Del Guadalhorce Health District-Andalusian Health Service-IBIMA-BIONAND Platform University of Malaga, Malaga, Spain.
European Network to Advance Best Practices and Technology on Medication AdherencE (ENABLE)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Medication adherence (MA) is a key challenge in healthcare. Literature about the real-world implementation of MA interventions across Europe remains poorly understood. This study aims to map MA interventions reported by experts across Europe. Study design: This cross-sectional study used a self-administered online survey targeting MA experts from 39 European countries. Experts were defined as professionals with clinical, policy, or research expertise in МА. Methods: Open-ended responses on expert-reported MA interventions were analysed using the framework method. The resulting categories were quantified at respondent level and described overall and by European region. Regional differences in the proportions of respondents reporting each intervention category were explored using exact tests, with adjustment for multiple comparisons. Results: A total of 140 MA experts from 35 European countries participated. Communication and education (83.6%) were the most frequently reported interventions, followed by follow-up and monitoring (53.6%), technological solutions (32.1%), and collaborative and multidisciplinary approaches (30.0%). Exploratory analyses identified regional differences in the reporting of collaborative and multidisciplinary approaches and technological solutions. Direct patient communication (35.0%) was the intervention most frequently perceived as successful by respondents and technological solutions were less frequently perceived as successful (12.9%). Conclusions: This study provides an expert-reported overview of MA interventions across European settings. Communication and education were the most frequently reported approaches, whereas technological and multidisciplinary interventions were reported less often. These findings support the need for further evaluation and more systematic integration of MA interventions across diverse European healthcare settings.

Indexed as

Adherence interventionsHealthcare professionalsMedication adherenceMedication adherence experts

Identifiers

PMID42774747
PMCPMC13595210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.